TY - JOUR
T1 - Mechanogenetics
T2 - harnessing mechanobiology for cellular engineering
AU - Nims, Robert J.
AU - Pferdehirt, Lara
AU - Guilak, Farshid
N1 - Publisher Copyright:
© 2021 Elsevier Ltd
PY - 2022/2
Y1 - 2022/2
N2 - ‘Mechanogenetics,’ a new field at the convergence of mechanobiology and synthetic biology, presents an innovative strategy to treat, repair, or restore diseased cells and tissues by harnessing mechanical signal transduction pathways to control gene expression. While the role of mechanical forces in regulating development, homeostasis, and disease is well established, only recently have we identified the specific mechanosensors and downstream signaling pathways involved in these processes. Simultaneously, synthetic biological systems are developing increasingly sophisticated approaches of controlling mammalian cellular responses. Continued mechanistic refinement and identification of how cellular mechanosensors respond to homeostatic and pathological mechanical forces, combined with synthetic tools to integrate and respond to these inputs, promises to extend the development of new therapeutic approaches for treating disease.
AB - ‘Mechanogenetics,’ a new field at the convergence of mechanobiology and synthetic biology, presents an innovative strategy to treat, repair, or restore diseased cells and tissues by harnessing mechanical signal transduction pathways to control gene expression. While the role of mechanical forces in regulating development, homeostasis, and disease is well established, only recently have we identified the specific mechanosensors and downstream signaling pathways involved in these processes. Simultaneously, synthetic biological systems are developing increasingly sophisticated approaches of controlling mammalian cellular responses. Continued mechanistic refinement and identification of how cellular mechanosensors respond to homeostatic and pathological mechanical forces, combined with synthetic tools to integrate and respond to these inputs, promises to extend the development of new therapeutic approaches for treating disease.
UR - http://www.scopus.com/inward/record.url?scp=85118320488&partnerID=8YFLogxK
U2 - 10.1016/j.copbio.2021.09.011
DO - 10.1016/j.copbio.2021.09.011
M3 - Review article
C2 - 34735987
AN - SCOPUS:85118320488
SN - 0958-1669
VL - 73
SP - 374
EP - 379
JO - Current Opinion in Biotechnology
JF - Current Opinion in Biotechnology
ER -